Investigating the role of the growth hormone-insulin-like growth factor (GH-IGF) axis as a determinant of male bone mineral density (BMD)

Bone. 2005 Dec;37(6):833-41. doi: 10.1016/j.bone.2005.06.016. Epub 2005 Sep 8.

Abstract

Introduction: The GH-IGF axis has profound effects on bone metabolism and may be important in the etiology of idiopathic osteoporosis. Serum IGF-I is often low in men with osteoporosis, which may be attributable to GH hypo-secretion or hepatic GH insensitivity. We studied the GH-IGF axis in depth to look for evidence to support these hypotheses.

Materials and methods: 28 healthy 60- to 70-year-old men with low, intermediate, or normal BMD were studied. GH secretion was measured by overnight urine collection. GH reserve was assessed by exercise and glucagon stimulation tests. Hepatic IGF-I production was investigated using a GH-IGF-I generation test. Data were analyzed using Pearson's correlation coefficient, linear regression, and analysis of variance.

Results: Serum IGF-I was reduced in subjects with low BMD (P = 0.009). There was no difference in GH secretion or reserve between the groups. Overall, GH reserve and IGF-I were positively related but this was attenuated in the low BMD group. However, no statistically significant difference in IGF-I generation capacity between BMD groups was found.

Conclusions: Men with reduced BMD have low IGF-I but normal GH secretion and reserve. Our data suggested, but could not confirm, hepatic resistance to GH as a mechanism for this association.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Biomarkers / blood
  • Bone Density* / drug effects
  • Bone Remodeling*
  • Exercise
  • Glucagon / administration & dosage
  • Growth Hormone / metabolism
  • Growth Hormone / urine*
  • Humans
  • Insulin-Like Growth Factor I / analysis*
  • Liver / chemistry*
  • Male
  • Middle Aged

Substances

  • Biomarkers
  • Insulin-Like Growth Factor I
  • Growth Hormone
  • Glucagon